🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
2.380
-0.170 (-6.67%)
At close: Nov 20, 2026, 4:00 PM EST
2.420
+0.040 (1.68%)
After-hours: Nov 20, 2026, 4:05 PM EST

TNXP Stock Forecast

TNXP's stock price has decreased by -85.89% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 5 analysts polled by S&P Global, TNXP stock has a consensus rating of "Strong Buy" and an average price target of $30. The average 1-year stock price forecast is 1,160.50% higher than the current stock price, while the lowest is $14 (+488.24%) and the highest is $56 (+2,252.94%).

Price Target: $30 (+1,160.50%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$14$30$22$56
Change+488.24%+1160.5%+824.37%+2252.9%

Analyst Ratings

The average analyst rating for TNXP stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy444344
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total444344

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Alliance Global Partners
Alliance Global Partners
Buy
Maintains
$65 → $40
BuyMaintains$65 → $40+1,580.67%Nov 10, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$18
BuyReiterates$18+656.30%Nov 10, 2026
Raymond James
Raymond James
Buy
Reiterates
$26 → $14
BuyReiterates$26 → $14+488.24%Nov 9, 2026
TD Cowen
TD Cowen
Buy
Maintains
$22
BuyMaintains$22+824.37%Oct 21, 2026

Financial Forecast

Revenue This Year
58.24M
from 13.11M
Increased by 344.37%
Revenue Next Year
109.81M
from 58.24M
Increased by 88.53%
EPS This Year
-10.92
from -14.68
EPS Next Year
-7.00
from -10.92
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--7.77M10.09M13.11M58.24M
Revenue Growth
---29.94%29.85%344.37%
Operating Income
-92.31M-112.09M-118.38M-77.74M-125.70M-193.09M
Net Income
-92.29M-110.22M-116.66M-130.04M-124.02M-186.01M
EPS
-----14.68-10.92
Free Cash Flow
------127.05M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High60.0M
Avg58.2M
Low57.2M

Revenue Growth

Revenue Growth202620272028
High
357.8%
Avg
344.4%
Low
336.4%

EPS Forecast

EPS202620272028
High-10.73
Avg-10.92
Low-11.10

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-